Tokyo Tape
Sign in
← SymBio Pharmaceuticals

Annual report

4582.TEDINET S100QFOG
Period2022-01-01 → 2022-12-31
Filed2023-03-23
StandardJapan GAAP
ConsolidatedYes
Data checks17 of 17 passed

Amended by S100QG6E (2023-03-24).

Key figures · 100
MetricValuePeriodScopeSource row
Revenue¥10.0bn2022-01-01 → 2022-12-31Cons.Net sales
Operating income¥2.0bn2022-01-01 → 2022-12-31Cons.Operating income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥2.1bn2022-01-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss
Total assets¥10.4bnat 2022-12-31Cons.Assets
Total liabilities¥1.9bnat 2022-12-31Cons.Liabilities
Net assets / equity¥8.5bnat 2022-12-31Cons.Net assets
Net assets / equity¥6.7bnat 2021-12-31Cons.Net assets
Cash and deposits¥6.3bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥6.3bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.9bnat 2021-12-31Cons.Cash and cash equivalents
Operating cash flow¥1.6bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥47m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥628m2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥30.22022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥29.772022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥204.83at 2022-12-31Cons.Net assets per share (5-year summary)
Equity ratio77.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
ROE14.6%2022-01-01 → 2022-12-31Cons.Rate of return on equity (5-year summary)
Employees122at 2022-12-31Cons.Number of employees
Revenue¥10.0bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥8.3bn2021-01-01 → 2021-12-31StandaloneNet sales
Revenue¥3.0bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥2.8bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Revenue¥3.8bn2018-01-01 → 2018-12-31dStandaloneNet sales (5-year summary)
Operating income¥2.0bn2022-01-01 → 2022-12-31StandaloneOperating income
Operating income¥1.0bn2021-01-01 → 2021-12-31StandaloneOperating income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥1.0bn2021-01-01 → 2021-12-31StandaloneOrdinary income
Ordinary income−¥4.6bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥2.7bn2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥2.1bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax¥1.0bn2021-01-01 → 2021-12-31StandaloneIncome before income taxes
Net income¥1.2bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥2.0bn2021-01-01 → 2021-12-31StandaloneProfit loss
Net income−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Net income−¥2.8bn2018-01-01 → 2018-12-31dStandaloneNet income loss (5-year summary)
Total assets¥10.4bnat 2022-12-31StandaloneAssets
Total assets¥8.5bnat 2021-12-31StandaloneAssets
Total assets¥6.3bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥5.3bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥6.2bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.9bnat 2022-12-31StandaloneLiabilities
Total liabilities¥1.7bnat 2021-12-31StandaloneLiabilities
Net assets / equity¥8.5bnat 2022-12-31StandaloneNet assets
Net assets / equity¥6.7bnat 2021-12-31StandaloneNet assets
Net assets / equity¥4.7bnat 2020-12-31dStandaloneNet assets
Net assets / equity¥4.4bnat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥4.9bnat 2018-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥6.3bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥3.9bnat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥3.9bnat 2021-12-31StandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.8bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.9bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥4.8bnat 2018-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥140m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥2.3bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥71m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥160m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥216m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥26m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥72m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.2bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.7bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.3bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥30.372022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.042021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-124.132020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-189.032019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-165.542018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥29.952022-01-01 → 2022-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥52.322021-01-01 → 2021-12-31StandaloneDiluted earnings per share (5-year summary)
Net assets per share¥204.95at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥162.26at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥105.76at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥143.07at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥212.23at 2018-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio77.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio73.7%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio64.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio71.7%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio70.1%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.6%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE39.6%2021-01-01 → 2021-12-31StandaloneRate of return on equity (5-year summary)
Shares issued39,603,606at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued38,457,206at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued38,202,956at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,437,681at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued83,398,924at 2018-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees118at 2022-12-31StandaloneNumber of employees
Employees141at 2021-12-31StandaloneNumber of employees
Employees127at 2020-12-31dStandaloneNumber of employees
Employees107at 2019-12-31dStandaloneNumber of employees
Employees90at 2018-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Research And Development Manufacturing And Sales Of Pharmaceuticals Etc And Related Businessreportable segmentemployeesat 2022-12-31122 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,061
ItemContextValueUnit
Interest income ope cfCurrentYearDuration-98000JPY
Foreign exchange losses gains ope cfCurrentYearDuration-370416000JPY
Commission fee ope cfCurrentYearDuration56543000JPY
Stock issuance cost ope cfCurrentYearDuration45867000JPY
Gain on reversal of subscription rights to shares ope cfCurrentYearDuration-106401000JPY
Loss on retirement of noncurrent assets ope cfCurrentYearDuration540000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYearDuration62594000JPY
Decrease increase in inventories ope cfCurrentYearDuration-82746000JPY
Decrease increase in prepaid expenses ope cfCurrentYearDuration-64874000JPY
Decrease increase in consumption taxes receivable payable ope cfCurrentYearDuration-270711000JPY
Decrease increase in other current assets ope cfCurrentYearDuration-89984000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYearDuration-23050000JPY
Increase decrease in accounts payable other ope cfCurrentYearDuration685306000JPY
Increase decrease in other current liabilities ope cfCurrentYearDuration-105844000JPY
Other net ope cfCurrentYearDuration157769000JPY
Subtotal ope cfCurrentYearDuration2034463000JPY
Interest and dividends income received ope cf inv cfCurrentYearDuration98000JPY
Commitment fee paid ope cfCurrentYearDuration-56543000JPY
Income taxes paid ope cfCurrentYearDuration-363776000JPY
Net cash provided by used in operating activitiesCurrentYearDuration1614241000JPY
Purchase of property plant and equipment inv cfCurrentYearDuration-2034000JPY
Purchase of intangible assets inv cfCurrentYearDuration-45524000JPY
Proceeds from collection of lease and guarantee deposits inv cfCurrentYearDuration432000JPY
Net cash provided by used in investment activitiesCurrentYearDuration-47127000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYearDuration146000JPY
Proceeds from issuance of subscription rights to shares fin cfCurrentYearDuration13760000JPY
Payments for issuance of common stock fin cfCurrentYearDuration-45837000JPY
Proceeds from issuance of common stock fin cfCurrentYearDuration662000000JPY
Purchase of treasury stock fin cfCurrentYearDuration-2165000JPY
Proceeds from disposal of treasury stock fin cfCurrentYearDuration81000JPY
Net cash provided by used in financing activitiesCurrentYearDuration627985000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYearDuration213710000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration2408809000JPY
Cash and cash equivalentsPrior1YearInstant3860106000JPY
Increase in cash and cash equivalents from newly consolidated subsidiary cceCurrentYearDuration13637000JPY
Cash and cash equivalentsCurrentYearInstant6282554000JPY
Number of consolidated subsidiariesCurrentYearInstant1
Promotion expenses sgaCurrentYearDuration1481789000JPY
Directors compensations sgaCurrentYearDuration122418000JPY
Payroll and allowances sgaCurrentYearDuration461895000JPY
Retirement benefit expenses sgaCurrentYearDuration699000JPY
Research and development expenses sgaCurrentYearDuration2554799000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodCurrentYearDuration2554799000JPY
Cash and depositsPrior1YearInstant_NonConsolidatedMember3860106000JPY
Cash and depositsCurrentYearInstant_NonConsolidatedMember6259561000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember2147510000JPY
Accounts receivable tradeCurrentYearInstant_NonConsolidatedMember2084915000JPY
Merchandise and finished goodsPrior1YearInstant_NonConsolidatedMember125265000JPY
Merchandise and finished goodsCurrentYearInstant_NonConsolidatedMember293757000JPY
Semi finished goodsPrior1YearInstant_NonConsolidatedMember259940000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 17 of 17 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identitynon_consolidated 2021-12-31pass rounding
balance sheet identitynon_consolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2020-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass